Refractory AML: Clinical Trials

1 trial for Refractory AML, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Refractory AML: new trials by email Literature Review of Refractory AML trials Research Report on Refractory AML

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX)
Venetoclax Oral Tablet - Relapsed Adult AML, Refractory AML
Phase 1 / Phase 2CompletedTechnische Universität Dresden552020-04-062026-09-02

Narrower conditions

Leukemia, Myeloid, Acute (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

venetoclax (1)

Sponsors

Technische Universität Dresden (1)

Countries

Germany (1)

Results publications

PMID 41791831